Currently, there are 380.70M common shares owned by the public and among those 373.62M shares have been available to trade.
The company’s stock has a 5-day price change of -2.93% and -50.27% over the past three months. VRT shares are trading -40.52% year to date (YTD), with the 12-month market performance down to -17.48% lower. It has a 12-month low price of $53.60 and touched a high of $155.84 over the same period. VRT has an average intraday trading volume of 12.12 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -7.60%, -22.04%, and -32.73% respectively.
Institutional ownership of Vertiv Holdings Co (NYSE: VRT) shares accounts for 82.98% of the company’s 380.70M shares outstanding.
It has a market capitalization of $25.73B and a beta (3y monthly) value of 1.70. The stock’s trailing 12-month PE ratio is 52.48, while the earnings-per-share (ttm) stands at $1.29. The company has a PEG of 2.41 and a Quick Ratio of 1.25 with the debt-to-equity ratio at 1.29. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.17% over the week and 8.48% over the month.
Analysts forecast that Vertiv Holdings Co (VRT) will achieve an EPS of 0.62 for the current quarter, 0.88 for the next quarter and 4.28 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.59 while analysts give the company a high EPS estimate of 0.59. Comparatively, EPS for the current quarter was 0.43 a year ago. Earnings per share for the fiscal year are expected to increase by 24.09%, and 21.14% over the next financial year.
Looking at the support for the VRT, a number of firms have released research notes about the stock. ROTH MKM stated their Buy rating for the stock in a research note on April 08, 2025, with the firm’s price target at $75. RBC Capital Mkts coverage for the Vertiv Holdings Co (VRT) stock in a research note released on March 07, 2025 offered a Outperform rating with a price target of $121. Melius was of a view on January 28, 2025 that the stock is Hold, while Morgan Stanley gave the stock Overweight rating on January 06, 2025, issuing a price target of $150. Barclays on their part issued Equal Weight rating on December 12, 2024.
